Stock

This biotech company is hard at work to win the coronavirus vaccine race. Will it succeed? All eyes are on the drug manufacturers that are racing to develop the first safe and efficacious coronavirus vaccine. Global COVID-19 cases have crossed the 15 million mark, with at least 634,000 deaths worldwide. In the United States alone,…

Two men suspected of stock theft in Stutterheim were burnt alive. Two people believed to be part of a three-member stock theft gang have been killed in an act of apparent mob justice.Subsistence and commercial farmers in Stutterheim have been under siege from thieves for years.Stutterheim police station ranks among the top 30 for stock…

Several areas across the City of Johannesburg have gone for over two weeks without electricity.The delay in repairing the outages has been caused by a lack of stock needed to carry out the repairs.Some stock has been obtained and repairs are expected to continue into the week.Several areas across the City of Johannesburg have gone…

U.S. equity futures are trading higher ahead of the Wednesday Wall Street session following promising news about an experimental vaccine for the coronavirus.The major futures indexes are suggesting a gain of 1.3 percent.GET FOX BUSINESS ON THE GO BY CLICKING HEREInvestors were encouraged by news that an experimental COVID-19 vaccine under development by Moderna and…

Published: July 14, 2020 at 6:23 p.m. ET New study shows ‘robust’ immune response to trial vaccine, Moderna says Moderna headquarters in Cambridge, Mass. Getty Images Moderna Inc. stock skyrocketed in the extended session Tuesday after the biotech company said its coronavirus vaccine candidate produced a “robust” immune-system response in a larger group of people…